Rowan Cos. PLC (RDC) Financials Nov 20, 2014, 4:16

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Rowan Cos. PLC (RDC) Financials Nov 20, 2014, 4:16 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Rowan Cos. PLC


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.77B 1.82B 939.23M 1.39B 1.58B
Cost of Goods Sold (COGS) incl. D&A 1.17B 1.25B 691.97M 1B 1.13B
COGS excluding D&A 1B 1.07B 487.1M 752.17M 860.89M
Depreciation & Amortization Expense 171.45M 186.56M 204.87M 247.9M 271.01M
Depreciation - - - 247.9M 271.01M
Amortization of Intangibles - - - 0 0
Gross Income 598.03M 566.35M 247.26M 392.53M 447.38M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 102.76M 132.59M 88.28M 114.01M 131.37M
Research & Development 0 0 0 0 0
Other SG&A 102.76M 132.59M 88.28M 114.01M 131.37M
Other Operating Expense 0 42.02M 4.88M 72,000 0
Unusual Expense 0 (5.32M) 6.1M 48.12M 4.45M
EBIT after Unusual Expense 0 5.32M (6.1M) (48.12M) (4.45M)
Non Operating Income/Expense 12.61M 5.32M 1.42M 3.12M 17.9M
Non-Operating Interest Income 1.24M 1.51M 730,000 745,000 1.58M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 8.03M 24.88M 20.07M 50.72M 69.79M
Gross Interest Expense 29.51M 64.88M 74.57M 84.12M 118.49M
Interest Capitalized 21.49M 40M 54.5M 33.4M 48.7M
Pretax Income 501.09M 379.02M 130.08M 183.47M 261.24M
Income Tax 133.59M 99.02M (5.66M) (19.83M) 8.66M
Income Tax - Current Domestic 53.4M 24.99M (39.14M) (69.83M) (43.17M)
Income Tax - Current Foreign 27.53M 34.69M 15.37M 23.93M 31.93M
Income Tax - Deferred Domestic 52.65M 39.34M 18.12M 26.07M 20.83M
Income Tax - Deferred Foreign - - - - (930,000)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 367.5M 280M 135.74M 203.3M 252.58M
Minority Interest Expense 0 0 0 0 0
Net Income 367.5M 280M 135.74M 203.3M 252.58M
Extraordinaries & Discontinued Operations 0 0 601.1M (22.7M) 0
Extra Items & Gain/Loss Sale Of Assets 0 0 598M 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 3.11M (22.7M) 0
Net Income After Extraordinaries 367.5M 280M 736.84M 180.6M 252.58M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 367.5M 280M 135.74M 203.3M 252.58M
EPS (Basic) 3.24 2.39 1.11 1.47 2.04
Basic Shares Outstanding 113.52M 117.02M 125.04M 123M 123.52M
EPS (Diluted) 3.24 2.36 1.10 1.46 2.03
Diluted Shares Outstanding 113.58M 118.82M 126.39M 123.87M 124.47M
EBITDA 666.71M 578.31M 358.98M 526.35M 587.02M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 7

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Space-ng's New Computer Vision Solutions

Updated Category News Views 125

Introducing Space-ng's Innovative Vision System Space-ng is excited to present a revolutionary Hardware Development Kit (HDK) and a Software Development Kit (SDK) tailored for their renowned Sol3 Vision System. This initiative embodies a commitment to affordable, rugged, and air-cooled technology suitable for space applications. The HDK is designed for rapid prototyping,...

Continue Reading
iOnctura Advances Treatment Options for Uveal Melanoma Patients

Updated Category News Views 182

iOnctura Reports Significant Clinical Progress in Uveal Melanoma iOnctura, a clinical-stage biopharmaceutical company, has recently unveiled critical advancements in its efforts to combat uveal melanoma, a rare form of eye cancer that often presents significant treatment challenges. The company has completed its Phase I DIONE-01 study, showcasing encouraging clinical...

Continue Reading
Spyre Therapeutics Progresses with SPY001 for IBD Treatment

Updated Category News Views 115

Spyre Therapeutics Reports Encouraging Phase 1 Trial Data Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, has recently released promising interim results from its Phase 1 trial of SPY001, an innovative half-life extended monoclonal antibody aimed at treating inflammatory bowel disease (IBD). The study indicates that SPY001 was well...

Continue Reading
Understanding the University of Phoenix Tuition Guarantee

Updated Category News Views 194

Understanding the University of Phoenix Tuition Guarantee Fixed tuition and new transparency initiatives support adult learners in planning educational expenses. University of Phoenix is enhancing its commitment to clear and consistent tuition costs through its Tuition Guarantee initiative. This program ensures that students benefit from a locked-in tuition rate from the...

Continue Reading
Halper Sadeh Investigates Shareholder Rights for IPXX, PWUP, DECA, TTNP

Updated Category News Views 38

Halper Sadeh LLC Investigates Shareholder Rights Halper Sadeh LLC, a law firm dedicated to protecting investor rights, is currently examining several companies for potential violations of federal securities laws and breaches of fiduciary duties. This investigation focuses on significant firms involved in mergers, with the aim of safeguarding shareholder interests....

Continue Reading